Roger S. McIntyre is Head of the Mood Disorders Psychopharmacology Unit, University Health Network, and Professor of Psychiatry and Pharmacology, University of Toronto, ON, Canada. Danielle S. Cha is a Researcher at the Institute of Medical Science, University of Toronto, and the Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.

Select Guide Rating

• Preface; Part I. Clinical Relevance of Cognitive Dysfunction in Major Depressive Disorder: 1. Does cognitive dysfunction predate the onset of incident depression? Julia Buthmann, Danielle S. Cha and Roger S. McIntyre; 2. Understanding the importance of cognitive dysfunction and cognitive change in major depressive disorder Paul Maruff and Judith Jaeger; 3. Cognition in MDD implications for primary care Larry Culpepper; 4. Neurocognition in pediatric depression Dwight Newton, Melanie Naiberg and Benjamin Goldstein; 5. Neuroanatomy of cognition in major depressive disorder (hot and cold) Guy M. Goodwin; 6. Hot and cold cognition in major depressive disorder Oliver Robinson, Jonathan Rosier and Barbara Sahakian; 7. Social cognition and emotional processing in major depressive disorder Philippe Fossati and Sophie Hinfray; 8. The role of social cognition in major depressive disorder Bernhard Baune and Michael Weightman; 9. Are cognitive deficits in major depressive disorder progressive? Philip Gorwood and Marie Laure Clery-Melin; 10. Implications of cognitive impairments on functional outcomes in major depressive disorder Tracy L. Greer and Cassandra R. Hatt; Part II. Underlying Biological Substrates Associated with Cognitive Dysfunction in Major Depressive Disorder: 11. Cognition and biomarkers in major depressive disorder (MDD): endophenotype or epiphenomenon? Shane McInerney, Philip Gorwood and Sidney Kennedy; 12. Inflammation and cognition in major depressive disorder Bernhard Baune; 13. HPA axis and cognitive dysfunction in mood disorders Rebecca Strawbridge and Allan H. Young; 14. White matter neurobiology and cognitive dysfunction in major depressive disorder Geoffrey Chern-Yee Tan and Kang Sim; 15. Insulin resistance and implications for hippocampal volume/function the default mode network Heather A. Kenna, Tonita E. Wroolie, Danielle R. Balzafiore and Natalie L. Rasgon; Part III. Evaluating Cognitive Dysfunction in Major Depressive Disorder: 16. Measuring the mind: detecting cognitive deficits and measuring cognitive change in patients with depression John Harrison; 17. Subjective measures of cognitive dysfunction in major depressive disorder Raymond Lam; Part IV. Treatment Opportunities for Ameliorating Cognitive Dysfunction in Major Depressive Disorder: 18. Neuroscience of functional outcomes and treatment targets in major depressive disorder Lisanne M. Jenkins, Amy Peters, Rachel H. Jacobs and Scott A. Langenecker; 19. Treatment of cognitive dysfunction in adults with major depressive disorder Roger S. McIntyre, Kahlood Syeda and Danielle S. Cha; 20. A novel treatment targeting cognitive dysfunction in mood disorders Kamilla W. Miskowiak; 21. Cognitive remediation for major depressive disorder Christopher Bowie; 22. Exercise and cognition Guy Faulkner, Mark Duncan and Mehala Subramaniapillai; Index.

Roger S. McIntyre is Head of the Mood Disorders Psychopharmacology Unit, University Health Network, and Professor of Psychiatry and Pharmacology, University of Toronto, ON, Canada. Danielle S. Cha is a Researcher at the Institute of Medical Science, University of Toronto, and the Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.

Select Guide Rating

• Preface; Part I. Clinical Relevance of Cognitive Dysfunction in Major Depressive Disorder: 1. Does cognitive dysfunction predate the onset of incident depression? Julia Buthmann, Danielle S. Cha and Roger S. McIntyre; 2. Understanding the importance of cognitive dysfunction and cognitive change in major depressive disorder Paul Maruff and Judith Jaeger; 3. Cognition in MDD implications for primary care Larry Culpepper; 4. Neurocognition in pediatric depression Dwight Newton, Melanie Naiberg and Benjamin Goldstein; 5. Neuroanatomy of cognition in major depressive disorder (hot and cold) Guy M. Goodwin; 6. Hot and cold cognition in major depressive disorder Oliver Robinson, Jonathan Rosier and Barbara Sahakian; 7. Social cognition and emotional processing in major depressive disorder Philippe Fossati and Sophie Hinfray; 8. The role of social cognition in major depressive disorder Bernhard Baune and Michael Weightman; 9. Are cognitive deficits in major depressive disorder progressive? Philip Gorwood and Marie Laure Clery-Melin; 10. Implications of cognitive impairments on functional outcomes in major depressive disorder Tracy L. Greer and Cassandra R. Hatt; Part II. Underlying Biological Substrates Associated with Cognitive Dysfunction in Major Depressive Disorder: 11. Cognition and biomarkers in major depressive disorder (MDD): endophenotype or epiphenomenon? Shane McInerney, Philip Gorwood and Sidney Kennedy; 12. Inflammation and cognition in major depressive disorder Bernhard Baune; 13. HPA axis and cognitive dysfunction in mood disorders Rebecca Strawbridge and Allan H. Young; 14. White matter neurobiology and cognitive dysfunction in major depressive disorder Geoffrey Chern-Yee Tan and Kang Sim; 15. Insulin resistance and implications for hippocampal volume/function the default mode network Heather A. Kenna, Tonita E. Wroolie, Danielle R. Balzafiore and Natalie L. Rasgon; Part III. Evaluating Cognitive Dysfunction in Major Depressive Disorder: 16. Measuring the mind: detecting cognitive deficits and measuring cognitive change in patients with depression John Harrison; 17. Subjective measures of cognitive dysfunction in major depressive disorder Raymond Lam; Part IV. Treatment Opportunities for Ameliorating Cognitive Dysfunction in Major Depressive Disorder: 18. Neuroscience of functional outcomes and treatment targets in major depressive disorder Lisanne M. Jenkins, Amy Peters, Rachel H. Jacobs and Scott A. Langenecker; 19. Treatment of cognitive dysfunction in adults with major depressive disorder Roger S. McIntyre, Kahlood Syeda and Danielle S. Cha; 20. A novel treatment targeting cognitive dysfunction in mood disorders Kamilla W. Miskowiak; 21. Cognitive remediation for major depressive disorder Christopher Bowie; 22. Exercise and cognition Guy Faulkner, Mark Duncan and Mehala Subramaniapillai; Index.

Roger S. McIntyre is Head of the Mood Disorders Psychopharmacology Unit, University Health Network, and Professor of Psychiatry and Pharmacology, University of Toronto, ON, Canada. Danielle S. Cha is a Researcher at the Institute of Medical Science, University of Toronto, and the Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.

Select Guide Rating

• Preface; Part I. Clinical Relevance of Cognitive Dysfunction in Major Depressive Disorder: 1. Does cognitive dysfunction predate the onset of incident depression? Julia Buthmann, Danielle S. Cha and Roger S. McIntyre; 2. Understanding the importance of cognitive dysfunction and cognitive change in major depressive disorder Paul Maruff and Judith Jaeger; 3. Cognition in MDD implications for primary care Larry Culpepper; 4. Neurocognition in pediatric depression Dwight Newton, Melanie Naiberg and Benjamin Goldstein; 5. Neuroanatomy of cognition in major depressive disorder (hot and cold) Guy M. Goodwin; 6. Hot and cold cognition in major depressive disorder Oliver Robinson, Jonathan Rosier and Barbara Sahakian; 7. Social cognition and emotional processing in major depressive disorder Philippe Fossati and Sophie Hinfray; 8. The role of social cognition in major depressive disorder Bernhard Baune and Michael Weightman; 9. Are cognitive deficits in major depressive disorder progressive? Philip Gorwood and Marie Laure Clery-Melin; 10. Implications of cognitive impairments on functional outcomes in major depressive disorder Tracy L. Greer and Cassandra R. Hatt; Part II. Underlying Biological Substrates Associated with Cognitive Dysfunction in Major Depressive Disorder: 11. Cognition and biomarkers in major depressive disorder (MDD): endophenotype or epiphenomenon? Shane McInerney, Philip Gorwood and Sidney Kennedy; 12. Inflammation and cognition in major depressive disorder Bernhard Baune; 13. HPA axis and cognitive dysfunction in mood disorders Rebecca Strawbridge and Allan H. Young; 14. White matter neurobiology and cognitive dysfunction in major depressive disorder Geoffrey Chern-Yee Tan and Kang Sim; 15. Insulin resistance and implications for hippocampal volume/function the default mode network Heather A. Kenna, Tonita E. Wroolie, Danielle R. Balzafiore and Natalie L. Rasgon; Part III. Evaluating Cognitive Dysfunction in Major Depressive Disorder: 16. Measuring the mind: detecting cognitive deficits and measuring cognitive change in patients with depression John Harrison; 17. Subjective measures of cognitive dysfunction in major depressive disorder Raymond Lam; Part IV. Treatment Opportunities for Ameliorating Cognitive Dysfunction in Major Depressive Disorder: 18. Neuroscience of functional outcomes and treatment targets in major depressive disorder Lisanne M. Jenkins, Amy Peters, Rachel H. Jacobs and Scott A. Langenecker; 19. Treatment of cognitive dysfunction in adults with major depressive disorder Roger S. McIntyre, Kahlood Syeda and Danielle S. Cha; 20. A novel treatment targeting cognitive dysfunction in mood disorders Kamilla W. Miskowiak; 21. Cognitive remediation for major depressive disorder Christopher Bowie; 22. Exercise and cognition Guy Faulkner, Mark Duncan and Mehala Subramaniapillai; Index.